GM board approves new $6 billion share buyback authorization

GM board approves new  billion share buyback authorization


General Motors CEO Mary Barra, center, at the New York Stock Exchange, Nov. 17, 2022.

Source: NYSE

DETROIT – General Motors on Tuesday announced a new $6 billion stock repurchase authorization has been approved by its board.

The new buyback authorization comes as an accelerated $10 billion share repurchase program announced in November 2023 is expected to be completed by the end of this month.

“We are very focused on the profitability of our [internal combustion engine] business, we’re growing and improving the profitability of our EV business and deploying our capital efficiently. This allows us to continue returning cash to shareholders,” GM CFO Paul Jacobson said in a release.

The new authorization will allow GM to opportunistically repurchase shares after the completion of the existing reauthorization, the automaker said. A timeframe for completion of the program was not announced.

Shares of GM were up 1% in premarket trading. The stock closed Monday at $47.57, up about 32.4% this year.

The announced buyback plans come amid uncertainty surrounding the adoption of all-electric vehicles, which GM has bet heavily on, and stalling customer demand for new vehicles.  

“The investments GM made in its brands and product portfolio over the last several years, and the company’s operating discipline, are delivering consistently strong revenue growth, margins and free cash flow,” Jacobson said.

Don’t miss these exclusives from CNBC PRO



Source

Amazon Pharmacy starts offering Novo Nordisk’s Wegovy weight-loss pill
Business

Amazon Pharmacy starts offering Novo Nordisk’s Wegovy weight-loss pill

Close-up of a hand holding a cellphone displaying the Amazon Pharmacy system, Lafayette, California, September 15, 2021.  Smith Collection | Gado | Getty Images Amazon announced Friday it now offers Novo Nordisk‘s Wegovy weight-loss pill through its digital pharmacy. Novo Nordisk began rolling out an oral version of its injectable obesity drug Wegovy in the […]

Read More
As tech stocks soar, executives use exchange funds to diversify wealth without selling
Business

As tech stocks soar, executives use exchange funds to diversify wealth without selling

Yuichiro Chino | Moment | Getty Images For executives and founders who have gotten rich off one stock, sometimes it is possible to have too much of a good thing. While the tech stock boom has meant a windfall for employees at high-flying companies, it’s risky to have too much of your net worth tied […]

Read More
How IMAX crushed other theater stocks in 2025
Business

How IMAX crushed other theater stocks in 2025

General atmosphere during an IMAX private screening for the movie “First Man” at an AMC theater in New York City on Oct. 10, 2018. Lars Niki | Getty Images Entertainment | Getty Images The theatrical industry is in flux — and one stock is rising above the rest. IMAX saw its shares jump more than […]

Read More